C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2612552
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
Composés qui agissent en tant qu'antagonistes puissants du récepteur CCR1 et possèdent une activité anti-inflammatoire in vivo. Lesdits composés sont généralement des dérivés d'aryle pipérazine et sont utiles dans des compositions pharmaceutiques, dans des méthodes de traitement de maladies médiées par CCR1, et en tant que témoins dans des analyses pour l'identification d'antagonistes compétitifs de CCR1.
Chen Wei
Leleti Manmohan R.
Li Lianfa
Li Yandong
Pennell Andrew M. K.
Chemocentryx Inc.
Fetherstonhaugh & Co.
LandOfFree
Azaindazole compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaindazole compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindazole compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1512742